173 related articles for article (PubMed ID: 38321773)
1. Progress of studies on natural products for glioblastoma therapy.
Xu F; Yang YH; Yang H; Li W; Hao Y; Zhang S; Zhang YZ; Cao WX; Li XX; Du GH; Ji TF; Wang JH
J Asian Nat Prod Res; 2024 Jan; 26(1):154-176. PubMed ID: 38321773
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.
Afshari AR; Mollazadeh H; Soukhtanloo M; Hosseini A; Mohtashami E; Jalili-Nik M; Modaresi SMS; Soltani A; Sahebkar A
Mini Rev Med Chem; 2020; 20(18):1879-1899. PubMed ID: 32767939
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention and therapeutic role of essential oils and phenolic compounds: Modeling tumor microenvironment in glioblastoma.
Magalhães M; Manadas B; Efferth T; Cabral C
Pharmacol Res; 2021 Jul; 169():105638. PubMed ID: 33933637
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
5. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway.
Soukhtanloo M; Mohtashami E; Maghrouni A; Mollazadeh H; Mousavi SH; Roshan MK; Tabatabaeizadeh SA; Hosseini A; Vahedi MM; Jalili-Nik M; Afshari AR
Pharmacol Rep; 2020 Apr; 72(2):285-295. PubMed ID: 32152926
[TBL] [Abstract][Full Text] [Related]
6. Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme.
Desai V; Bhushan A
Biomed Res Int; 2017; 2017():9363040. PubMed ID: 29359162
[TBL] [Abstract][Full Text] [Related]
7. Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway.
Afshari AR; Mollazadeh H; Mohtashami E; Soltani A; Soukhtanloo M; Hosseini A; Jalili-Nik M; Vahedi MM; Roshan MK; Sahebkar A
Curr Med Chem; 2021; 28(2):377-400. PubMed ID: 32000638
[TBL] [Abstract][Full Text] [Related]
8. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
9. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
Agarwal S; Muniyandi P; Maekawa T; Kumar DS
Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
[TBL] [Abstract][Full Text] [Related]
10. Current Development of Glioblastoma Therapeutic Agents.
Wang Z; Peet NP; Zhang P; Jiang Y; Rong L
Mol Cancer Ther; 2021 Sep; 20(9):1521-1532. PubMed ID: 34172531
[TBL] [Abstract][Full Text] [Related]
11. Natural substances to potentiate canonical glioblastoma chemotherapy.
Arcella A; Sanchez M
J Chemother; 2021 Sep; 33(5):276-287. PubMed ID: 33468026
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
Bastiancich C; Danhier P; Préat V; Danhier F
J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
[TBL] [Abstract][Full Text] [Related]
13. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Drug Resistance in Glioblastoma.
Dymova MA; Kuligina EV; Richter VA
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203727
[TBL] [Abstract][Full Text] [Related]
16. Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A.
Dai Z; Liu H; Wang B; Yang D; Zhu YY; Yan H; Zhu PF; Liu YP; Chen HC; Zhao YL; Zhao LX; Zhao XD; Liu HY; Luo XD
Eur J Med Chem; 2021 Jan; 210():113068. PubMed ID: 33310292
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
[TBL] [Abstract][Full Text] [Related]
18. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
[TBL] [Abstract][Full Text] [Related]
19. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
20. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
